These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17896967)
21. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
22. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation. Sluis-Cremer N; Arion D; Abram ME; Parniak MA Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348 [TBL] [Abstract][Full Text] [Related]
23. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions. Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326 [TBL] [Abstract][Full Text] [Related]
24. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861 [TBL] [Abstract][Full Text] [Related]
25. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein. Loregian A; Bortolozzo K; Boso S; Sapino B; Betti M; Biasolo MA; Caputo A; Palú G J Cell Physiol; 2003 Aug; 196(2):251-7. PubMed ID: 12811817 [TBL] [Abstract][Full Text] [Related]
26. The thumb domain of the P51-subunit is essential for activation of HIV reverse transcriptase. Morris MC; Berducou C; Mery J; Heitz F; Divita G Biochemistry; 1999 Nov; 38(46):15097-103. PubMed ID: 10563792 [TBL] [Abstract][Full Text] [Related]
27. Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. Hooker CW; Lott WB; Harrich D J Virol; 2001 Apr; 75(7):3095-104. PubMed ID: 11238836 [TBL] [Abstract][Full Text] [Related]
28. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication. Tekeste SS; Wilkinson TA; Weiner EM; Xu X; Miller JT; Le Grice SF; Clubb RT; Chow SA J Virol; 2015 Dec; 89(23):12058-69. PubMed ID: 26401032 [TBL] [Abstract][Full Text] [Related]
29. Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization. Tachedjian G; Aronson HE; de los Santos M; Seehra J; McCoy JM; Goff SP J Mol Biol; 2003 Feb; 326(2):381-96. PubMed ID: 12559908 [TBL] [Abstract][Full Text] [Related]
30. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Kamine J; Elangovan B; Subramanian T; Coleman D; Chinnadurai G Virology; 1996 Feb; 216(2):357-66. PubMed ID: 8607265 [TBL] [Abstract][Full Text] [Related]
31. Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme. Tasara T; Amacker M; Hübscher U Biochemistry; 1999 Feb; 38(5):1633-42. PubMed ID: 9931031 [TBL] [Abstract][Full Text] [Related]
32. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Tachedjian G; Orlova M; Sarafianos SG; Arnold E; Goff SP Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7188-93. PubMed ID: 11416202 [TBL] [Abstract][Full Text] [Related]
33. HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. Lemay J; Maidou-Peindara P; Bader T; Ennifar E; Rain JC; Benarous R; Liu LX Retrovirology; 2008 Jun; 5():47. PubMed ID: 18544151 [TBL] [Abstract][Full Text] [Related]
34. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation. Majello B; Napolitano G; Lania L AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863 [TBL] [Abstract][Full Text] [Related]
35. Human Immunodeficiency Virus type 1 reverse transcriptase. Hottiger M; Hübscher U Biol Chem Hoppe Seyler; 1996 Feb; 377(2):97-120. PubMed ID: 8868066 [TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s). Song CZ; Loewenstein PM; Green M Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769 [TBL] [Abstract][Full Text] [Related]
37. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Parada CA; Roeder RG Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526 [TBL] [Abstract][Full Text] [Related]
38. The role of Tat in HIV-1 replication: an activator and/or a suppressor? Liang C; Wainberg MA AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784 [TBL] [Abstract][Full Text] [Related]
39. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR. Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986 [TBL] [Abstract][Full Text] [Related]
40. Mixed reconstitution of mutated subunits of HIV-1 reverse transcriptase coexpressed in Escherichia coli - two tags tie it up. Maier G; Dietrich U; Panhans B; Schröder B; Rübsamen-Waigmann H; Cellai L; Hermann T; Heumann H Eur J Biochem; 1999 Apr; 261(1):10-8. PubMed ID: 10103027 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]